雌激素受体-话题@MedSci

#雌激素受体#

43篇内容 | 1380人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1503487, encodeId=e0f8150348e1d, content=<a href='/topic/show?id=59d798e61f0' target=_blank style='color:#2F92EE;'>#雌激素受体#</a>, objectTitle=NPJ Breast Cancer：卵巢切除术显著影响绝经前雌激素受体阳性乳腺癌基因表达, objectType=article, longId=129988, objectId=874112998818, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=874112998818, replyNumber=0, likeNumber=34, createdTime=2018-02-16, rootId=0, userName=surilei, userId=ae6c9649886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=874112998818, moduleTitle=NPJ Breast Cancer：卵巢切除术显著影响绝经前雌激素受体阳性乳腺癌基因表达, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=874112998818)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1503486, encodeId=cb22150348674, content=<a href='/topic/show?id=59d798e61f0' target=_blank style='color:#2F92EE;'>#雌激素受体#</a>, objectTitle=Oncogenesis：伊马替尼或可靶向治疗某些雌激素受体阳性乳腺小叶浸润癌, objectType=article, longId=129984, objectId=0c2c129984d3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0c2c129984d3, replyNumber=0, likeNumber=28, createdTime=2018-02-16, rootId=0, userName=surilei, userId=ae6c9649886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0c2c129984d3, moduleTitle=Oncogenesis：伊马替尼或可靶向治疗某些雌激素受体阳性乳腺小叶浸润癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0c2c129984d3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1503485, encodeId=4dbd150348524, content=<a href='/topic/show?id=59d798e61f0' target=_blank style='color:#2F92EE;'>#雌激素受体#</a>, objectTitle=JNCI：雌激素和乳腺癌之间到底什么关系？高异质性的雌激素受体竟会加倍死亡风险！, objectType=article, longId=127550, objectId=055412e55082, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=055412e55082, replyNumber=0, likeNumber=34, createdTime=2018-01-26, rootId=0, userName=surilei, userId=ae6c9649886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=055412e55082, moduleTitle=JNCI：雌激素和乳腺癌之间到底什么关系？高异质性的雌激素受体竟会加倍死亡风险！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=055412e55082)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1503484, encodeId=62c81503484c2, content=<a href='/topic/show?id=59d798e61f0' target=_blank style='color:#2F92EE;'>#雌激素受体#</a>, objectTitle=Cancer Res：重磅！首次确认HER2驱动型乳腺癌与该雌激素受体结合蛋白有关！, objectType=article, longId=126196, objectId=11a9126196bd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=11a9126196bd, replyNumber=0, likeNumber=31, createdTime=2018-01-12, rootId=0, userName=surilei, userId=ae6c9649886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=11a9126196bd, moduleTitle=Cancer Res：重磅！首次确认HER2驱动型乳腺癌与该雌激素受体结合蛋白有关！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=11a9126196bd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1503483, encodeId=cea5150348327, content=<a href='/topic/show?id=59d798e61f0' target=_blank style='color:#2F92EE;'>#雌激素受体#</a>, objectTitle=Lancet oncol：Buparlisib联合氟维司群用于内分泌疗法和mTOR抑制剂治疗失败的雌激素受体阳性、HER2阴性的晚期乳腺癌患者的效果和安全性。, objectType=article, longId=122620, objectId=45fb122620ba, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=45fb122620ba, replyNumber=0, likeNumber=26, createdTime=2017-12-08, rootId=0, userName=surilei, userId=ae6c9649886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=45fb122620ba, moduleTitle=Lancet oncol：Buparlisib联合氟维司群用于内分泌疗法和mTOR抑制剂治疗失败的雌激素受体阳性、HER2阴性的晚期乳腺癌患者的效果和安全性。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=45fb122620ba)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1503482, encodeId=b986150348217, content=<a href='/topic/show?id=59d798e61f0' target=_blank style='color:#2F92EE;'>#雌激素受体#</a>, objectTitle=Prostate：前列腺癌中的雌激素受体信号分析, objectType=article, longId=119934, objectId=2faa119934c8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2faa119934c8, replyNumber=0, likeNumber=28, createdTime=2017-11-15, rootId=0, userName=surilei, userId=ae6c9649886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2faa119934c8, moduleTitle=Prostate：前列腺癌中的雌激素受体信号分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2faa119934c8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1503481, encodeId=402915034812d, content=<a href='/topic/show?id=59d798e61f0' target=_blank style='color:#2F92EE;'>#雌激素受体#</a>, objectTitle=NEJM：早期雌激素受体阳性乳腺癌患者内分泌治疗后5-20年复发风险及影响因素研究, objectType=article, longId=119387, objectId=842511938e6a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=842511938e6a, replyNumber=0, likeNumber=41, createdTime=2017-11-11, rootId=0, userName=surilei, userId=ae6c9649886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=842511938e6a, moduleTitle=NEJM：早期雌激素受体阳性乳腺癌患者内分泌治疗后5-20年复发风险及影响因素研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=842511938e6a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1503480, encodeId=aac91503480d9, content=<a href='/topic/show?id=59d798e61f0' target=_blank style='color:#2F92EE;'>#雌激素受体#</a>, objectTitle=Radiology：雌激素受体阳性乳腺癌复发风险？定性放射基因学组来说道说道！, objectType=article, longId=115243, objectId=57fd11524321, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=57fd11524321, replyNumber=0, likeNumber=31, createdTime=2017-10-06, rootId=0, userName=surilei, userId=ae6c9649886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=57fd11524321, moduleTitle=Radiology：雌激素受体阳性乳腺癌复发风险？定性放射基因学组来说道说道！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=57fd11524321)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1503479, encodeId=a11315034e94c, content=<a href='/topic/show?id=59d798e61f0' target=_blank style='color:#2F92EE;'>#雌激素受体#</a>, objectTitle=JCEM：雌激素受体β基因变异与盐敏感性高血压相关, objectType=article, longId=114932, objectId=75a311493265, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=75a311493265, replyNumber=0, likeNumber=33, createdTime=2017-10-01, rootId=0, userName=surilei, userId=ae6c9649886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=75a311493265, moduleTitle=JCEM：雌激素受体β基因变异与盐敏感性高血压相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=75a311493265)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1503478, encodeId=9bb715034e8a1, content=<a href='/topic/show?id=59d798e61f0' target=_blank style='color:#2F92EE;'>#雌激素受体#</a>, objectTitle=Int J GynecolCancer：阿那曲唑治疗雌激素受体或孕激素受体阳性的铂类耐药的复发性卵巢癌患者的二期临床试验, objectType=article, longId=103156, objectId=d8d010315642, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d8d010315642, replyNumber=0, likeNumber=17, createdTime=2017-06-25, rootId=0, userName=surilei, userId=ae6c9649886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d8d010315642, moduleTitle=Int J GynecolCancer：阿那曲唑治疗雌激素受体或孕激素受体阳性的铂类耐药的复发性卵巢癌患者的二期临床试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d8d010315642)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1503477, encodeId=dcc015034e787, content=<a href='/topic/show?id=59d798e61f0' target=_blank style='color:#2F92EE;'>#雌激素受体#</a>, objectTitle=Environ Pollut：PNP危害雌性生殖健康或许是通过抑制雌激素受体β的表达, objectType=article, longId=101088, objectId=7a22101088e0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7a22101088e0, replyNumber=0, likeNumber=41, createdTime=2017-06-09, rootId=0, userName=surilei, userId=ae6c9649886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7a22101088e0, moduleTitle=Environ Pollut：PNP危害雌性生殖健康或许是通过抑制雌激素受体β的表达, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7a22101088e0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1503476, encodeId=157515034e6ef, content=<a href='/topic/show?id=59d798e61f0' target=_blank style='color:#2F92EE;'>#雌激素受体#</a>, objectTitle=Sci Rep：肝雌激素受体α对于调节男性的糖原异常和脂质代谢至关重要！, objectType=article, longId=98646, objectId=ce6098646d5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ce6098646d5, replyNumber=0, likeNumber=49, createdTime=2017-05-14, rootId=0, userName=surilei, userId=ae6c9649886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ce6098646d5, moduleTitle=Sci Rep：肝雌激素受体α对于调节男性的糖原异常和脂质代谢至关重要！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ce6098646d5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1503475, encodeId=2b9b15034e5a1, content=<a href='/topic/show?id=59d798e61f0' target=_blank style='color:#2F92EE;'>#雌激素受体#</a>, objectTitle=Science：雌激素受体（ER）阳性乳腺癌抵抗PI3K抑制剂疗法的原因, objectType=article, longId=93347, objectId=0be19334e37, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0be19334e37, replyNumber=0, likeNumber=46, createdTime=2017-03-26, rootId=0, userName=surilei, userId=ae6c9649886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0be19334e37, moduleTitle=Science：雌激素受体（ER）阳性乳腺癌抵抗PI3K抑制剂疗法的原因, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0be19334e37)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1503474, encodeId=ec1d15034e489, content=<a href='/topic/show?id=59d798e61f0' target=_blank style='color:#2F92EE;'>#雌激素受体#</a>, objectTitle=引发雌激素受体阳性或阴性乳腺癌的风险因素是否扮演着相同的角色？, objectType=article, longId=87775, objectId=93e38e7752a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=93e38e7752a, replyNumber=0, likeNumber=31, createdTime=2017-01-20, rootId=0, userName=surilei, userId=ae6c9649886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=93e38e7752a, moduleTitle=引发雌激素受体阳性或阴性乳腺癌的风险因素是否扮演着相同的角色？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=93e38e7752a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1503473, encodeId=358f15034e3b0, content=<a href='/topic/show?id=59d798e61f0' target=_blank style='color:#2F92EE;'>#雌激素受体#</a>, objectTitle=Lancet：对于雌激素受体阳性的晚期乳腺癌患者氟维司群疗效比阿那曲唑更好, objectType=article, longId=83273, objectId=a635832e3b6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a635832e3b6, replyNumber=0, likeNumber=32, createdTime=2016-12-01, rootId=0, userName=surilei, userId=ae6c9649886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a635832e3b6, moduleTitle=Lancet：对于雌激素受体阳性的晚期乳腺癌患者氟维司群疗效比阿那曲唑更好, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a635832e3b6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1503472, encodeId=c14a15034e2ee, content=<a href='/topic/show?id=59d798e61f0' target=_blank style='color:#2F92EE;'>#雌激素受体#</a>, objectTitle=Breast Cancer Res：福音！他汀类药物或可有效治疗雌激素受体阳性的乳腺癌女性, objectType=article, longId=69839, objectId=015a69839d9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=015a69839d9, replyNumber=0, likeNumber=34, createdTime=2016-06-04, rootId=0, userName=surilei, userId=ae6c9649886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=015a69839d9, moduleTitle=Breast Cancer Res：福音！他汀类药物或可有效治疗雌激素受体阳性的乳腺癌女性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=015a69839d9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1503471, encodeId=856b15034e10e, content=<a href='/topic/show?id=59d798e61f0' target=_blank style='color:#2F92EE;'>#雌激素受体#</a>, objectTitle=Cell Reports：雌激素受体对男性前列腺很重要！, objectType=article, longId=49022, objectId=0bb14902243, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0bb14902243, replyNumber=0, likeNumber=26, createdTime=2015-04-08, rootId=0, userName=surilei, userId=ae6c9649886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0bb14902243, moduleTitle=Cell Reports：雌激素受体对男性前列腺很重要！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0bb14902243)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1503470, encodeId=978d15034e08d, content=<a href='/topic/show?id=59d798e61f0' target=_blank style='color:#2F92EE;'>#雌激素受体#</a>, objectTitle=雌激素受体阳性乳腺癌的新治疗方法, objectType=article, longId=44180, objectId=7af44418035, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7af44418035, replyNumber=0, likeNumber=39, createdTime=2014-12-19, rootId=0, userName=surilei, userId=ae6c9649886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7af44418035, moduleTitle=雌激素受体阳性乳腺癌的新治疗方法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7af44418035)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1503469, encodeId=7bb31503469b0, content=<a href='/topic/show?id=59d798e61f0' target=_blank style='color:#2F92EE;'>#雌激素受体#</a>, objectTitle=Nat Genet：转移性乳腺癌中雌激素受体编码基因或变异, objectType=article, longId=28805, objectId=7d1c2880500, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7d1c2880500, replyNumber=0, likeNumber=30, createdTime=2014-01-04, rootId=0, userName=surilei, userId=ae6c9649886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7d1c2880500, moduleTitle=Nat Genet：转移性乳腺癌中雌激素受体编码基因或变异, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7d1c2880500)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1503468, encodeId=b5c215034681d, content=<a href='/topic/show?id=59d798e61f0' target=_blank style='color:#2F92EE;'>#雌激素受体#</a>, objectTitle=Lancet：持续三苯氧胺治疗10年能降低雌激素受体阳性的乳腺癌患者的复发率和死亡率, objectType=article, longId=18294, objectId=ae70182943f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ae70182943f, replyNumber=0, likeNumber=36, createdTime=2013-05-08, rootId=0, userName=surilei, userId=ae6c9649886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ae70182943f, moduleTitle=Lancet：持续三苯氧胺治疗10年能降低雌激素受体阳性的乳腺癌患者的复发率和死亡率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ae70182943f)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

雌激素受体

2020-05-29

surilei (审核中...)

前往app查看评论内容

#雌激素受体#

NPJ Breast Cancer：卵巢切除术显著影响绝经前雌激素受体阳性乳腺癌基因表达

2018-02-16

surilei (审核中...)

前往app查看评论内容

#雌激素受体#

Oncogenesis：伊马替尼或可靶向治疗某些雌激素受体阳性乳腺小叶浸润癌

2018-02-16

surilei (审核中...)

前往app查看评论内容

#雌激素受体#

JNCI：雌激素和乳腺癌之间到底什么关系？高异质性的雌激素受体竟会加倍死亡风险！

2018-01-26

surilei (审核中...)

前往app查看评论内容

#雌激素受体#

Cancer Res：重磅！首次确认HER2驱动型乳腺癌与该雌激素受体结合蛋白有关！

2018-01-12

surilei (审核中...)

前往app查看评论内容

#雌激素受体#

Lancet oncol：Buparlisib联合氟维司群用于内分泌疗法和mTOR抑制剂治疗失败的雌激素受体阳性、HER2阴性的晚期乳腺癌患者的效果和安全性。

2017-12-08

surilei (审核中...)

前往app查看评论内容

#雌激素受体#

Prostate：前列腺癌中的雌激素受体信号分析

2017-11-15

surilei (审核中...)

前往app查看评论内容

#雌激素受体#

NEJM：早期雌激素受体阳性乳腺癌患者内分泌治疗后5-20年复发风险及影响因素研究

2017-11-11

surilei (审核中...)

前往app查看评论内容

#雌激素受体#

Radiology：雌激素受体阳性乳腺癌复发风险？定性放射基因学组来说道说道！

2017-10-06

surilei (审核中...)

前往app查看评论内容

#雌激素受体#

JCEM：雌激素受体β基因变异与盐敏感性高血压相关

2017-10-01

surilei (审核中...)

前往app查看评论内容

#雌激素受体#

Int J GynecolCancer：阿那曲唑治疗雌激素受体或孕激素受体阳性的铂类耐药的复发性卵巢癌患者的二期临床试验

2017-06-25

surilei (审核中...)

前往app查看评论内容

#雌激素受体#

Environ Pollut：PNP危害雌性生殖健康或许是通过抑制雌激素受体β的表达

2017-06-09

surilei (审核中...)

前往app查看评论内容

#雌激素受体#

Sci Rep：肝雌激素受体α对于调节男性的糖原异常和脂质代谢至关重要！

2017-05-14

surilei (审核中...)

前往app查看评论内容

#雌激素受体#

Science：雌激素受体（ER）阳性乳腺癌抵抗PI3K抑制剂疗法的原因

2017-03-26

surilei (审核中...)

前往app查看评论内容

#雌激素受体#

引发雌激素受体阳性或阴性乳腺癌的风险因素是否扮演着相同的角色？

2017-01-20

surilei (审核中...)

前往app查看评论内容

#雌激素受体#

Lancet：对于雌激素受体阳性的晚期乳腺癌患者氟维司群疗效比阿那曲唑更好

2016-12-01

surilei (审核中...)

前往app查看评论内容

#雌激素受体#

Breast Cancer Res：福音！他汀类药物或可有效治疗雌激素受体阳性的乳腺癌女性

2016-06-04

surilei (审核中...)

前往app查看评论内容

#雌激素受体#

Cell Reports：雌激素受体对男性前列腺很重要！

2015-04-08

surilei (审核中...)

前往app查看评论内容

#雌激素受体#

雌激素受体阳性乳腺癌的新治疗方法

2014-12-19

surilei (审核中...)

前往app查看评论内容

#雌激素受体#

Nat Genet：转移性乳腺癌中雌激素受体编码基因或变异

2014-01-04

surilei (审核中...)

前往app查看评论内容

#雌激素受体#

Lancet：持续三苯氧胺治疗10年能降低雌激素受体阳性的乳腺癌患者的复发率和死亡率

2013-05-08

科室
- - 订阅+
  - 更多科室
工具
服务